Health economics and policy challenges in global emerging markets / Mihajlo Jakovljevic, MD, PhD, editor.

Format:

Book

Contributor:

Jakovljevic, Mihajlo, editor.

Series:

Public health in the 21st century series.

Public Health in the 21st Century

Language:

English

Subjects (All):

Medical economics.

Medical policy.

World health.

Physical Description:

1 online resource (192 p.)

Place of Publication:

New York : Nova Publishers, 2016.

Language Note:

English

Summary:

This book is an attempt to tackle some of the key global health challenges with a focus on the leading, emerging countries and mature free-market economies facing similar issues. It consists of seven chapters written by well-recognized scholars in the field affiliated to academia, pharmaceutical industry and hospital sectors based in Japan, USA, China, Germany, Netherlands, Switzerland, Ireland, Serbia, Bulgaria, Poland and Albania. The contributors had diverse expert profiles in health economics, clinical medicine, public health and population aging. Regional health care issues were processed and referred to the BRICS and N-11 nations, North American region, Far East Asia, Western and Eastern Europe. Some of the difficulties of contemporary health systems tackled in certain chapters were: population aging, health spending, insurance coverage, health technology assessment, costs of pharmaceutical development, neurological disorder and diabetes economics, public health legislation and caregiver assessment in a traditional Asian setting. All of the aforementioned research might give a dynamic impetus and expand a mental horizon to the professionals dealing with these issues. We believe that this book deserves a broad global audience consisting of health care professionals, policy makers, health economists, clinical physicians and lay persons eager to expand their knowledge in the field. Our attitude is based on the worldwide academic recognition of the listed contributors. The degree of success of these ambitiously targeted efforts will be assessed by our esteemed audience in years to come.

Contents:

HEALTH ECONOMICS AND POLICY CHALLENGES IN GLOBAL EMERGING MARKETS ; HEALTH ECONOMICS AND POLICY CHALLENGES IN GLOBAL EMERGING MARKETS ; Library of Congress Cataloging-in-Publication Data; CONTENTS ; PREFACE ; Chapter 1 BRICS VS. N-11: POPULATION AGING AND HEALTH EXPENDITURES IN GLOBAL EMERGING MARKETS- HISTORICALS RECORDS AND UN FORECASTS 1975 - 2025 ; ABSTRACT ; INTRODUCTION ; METHODS ; Data Sources; Data Analysis ; RESULTS ; DISCUSSION; STUDY LIMITATIONS ; CONCLUSION; ACKNOWLEDGMENTS ; REFERENCES

Chapter 2 WHAT CAN EMERGING MARKETS LEARN FROM A PUBLIC LONG-TERM CARE INSURANCE SYSTEM FROM A MATURE COUNTRY: EXPERIMENTAL STUDY? ABSTRACT ; INTRODUCTION ; METHODS; The Public Long-Term Care Insurance (LTCI) System in Japan ; Introduction of the LTCI System in Japan ; A Structural Model to Measure the Effect of Public Long-Term Care Insurance System on Welfare Changes in Households ; EMPIRICAL AND EXPERIMENTAL RESULTS AND ANALYSIS ; The Data Set ; The Robust OLS Results for the Pooled Cross Section Data Set ; The Robust OLS Results for the Two-Year Data Set (2000 and 2003) in Table 6

Calculation of Values of Risk, Loss Variance and Absolute Risk Aversion (ARA) Discussion about the Factor of Economic Recession ; SUMMARY AND CONCLUSION; REFERENCES ; Chapter 3 INCORPORATION OF MULTI-CRITERIA DECISION ANALYSIS INTO HEALTH TECHNOLOGY ASSESSMENT: EXPERIENCES AND CHALLENGES FROM BULGARIA ; ABSTRACT; INTRODUCTION ; METHODS ; Key Theoretical Issues of MCDA ; Selecting Criteria ; Generic and Case-Specific MCDA Models ; International Experience on Combining HTA and MCDA ; From a Single ICER Measure to a Broader Set of Criteria ; Practical Lessons from Real-World MCDA Models

Incorporation of MCDA into HTA in BulgariaThe Bulgarian Experience in Incorporating MCDA into HTA ; Weaknesses of the Bulgarian HTA Process ; Weaknesses of the Bulgarian MCDA Framework ; CONCLUSION ; REFERENCES ; Chapter 4 WILLINGNESS-TO-PAY FOR A NEW PHARMACEUTICAL: IS IT WORTH THE MONEY? WHOSE MONEY? ; ABSTRACT ; 1. INTRODUCTION ; 2. LITERATURE REVIEW ; Cost-Effectiveness Studies ; WTP Studies ; 3. THE EXPERIMENT ; Sample and Interview Strategy ; Questionnaire ; Attributes ; Pretest and Design ; 4. EX-ANTE VS. EX-POST WILLINGNESS TO PAY ; 5. HYPOTHESES ; 6. DATA: DESCRIPTIVE STATISTICS

7. EMPIRICAL RESULTS7.1. Willingness-to-Pay Values ; 7.2. Willingness-to-Pay Values Across Subgroups ; CONCLUSION ; DISCLAIMER; REFERENCES ; Chapter 5 THE HEALTH ECONOMICS OF NON-EPILEPTIC ATTACK DISORDER IN IRELAND ; ABSTRACT ; INTRODUCTION ; Incidence and Prevalence of NEAD in Ireland ; Estimation of Costs; Cost-of-Illness Analysis ; Measurement of Costs ; Incidence of NEAD in Ireland ; Using Iceland Figures (Sigurdardottir and Olafsson, 1998) ; Using Hamilton County, Ohio, Figures (Szflarski et al. 2000) ; Economic Cost of NEAD in Ireland ; Prevalence Based Cost-of-Illness

Incidence Based Cost of Illness

Notes:

Description based upon print version of record.

Includes bibliographical references at the end of each chapters and index.

Description based on print version record.

ISBN:

1-63484-720-2